AfriPharma Health Systems is building a vertically integrated pharmaceutical distribution and healthcare access platform across the SADC region — anchored by a long-term WHO-aligned sterile injectable manufacturing strategy.
Across Southern Africa, essential medicines remain difficult to access — due to fragmented supply chains, weak distribution infrastructure, and limited local manufacturing. AfriPharma was founded to address this directly.
Our approach is deliberate: start with distribution, build operational credibility, generate cash flows, and use that foundation to anchor future manufacturing at scale.
An integrated healthcare access platform built for Southern Africa — connecting pharmacy services, care coordination, and pharmaceutical distribution.
Patient-centered pharmacy services including prescription fulfillment, chronic disease support, medication counseling, and home delivery — starting in Zimbabwe.
Healthcare coordination for diaspora families — covering medication management, appointment support, home delivery, and family reporting for loved ones back home.
A MCAZ-compliant, GDP-aligned distribution platform connecting manufacturers, hospitals, clinics, pharmacies, and NGOs across Zimbabwe and the SADC region.
Helping diaspora families coordinate trusted healthcare for loved ones across Southern Africa — through medication support, appointment coordination, and family updates.
Prescription coordination, refill reminders, medication tracking, and WhatsApp-based family support.
Everything in Essential, plus home delivery, proactive refill management, and monthly family updates.
Full healthcare navigation, appointment coordination, wellness verification, and dedicated care support.
Premium concierge care coordination for complex healthcare needs and executive health management.
A phased, market-by-market rollout — building operational depth before expanding breadth.
Incorporated April 2026. MCAZ WDP in progress.
Incorporated April 2026.
Entity formation planned. Technical and supply chain development underway.
Entity formation planned.
.
AfriPharma's distribution platform is the first chapter. The long-term goal is WHO-aligned sterile injectable manufacturing at scale — strengthening medicine security throughout the SADC region.
AfriPharma's anchor manufacturing product manufactured to EU GMP Annex 1 standards and targeting WHO Prequalification — addressing one of sub-Saharan Africa's most critical medicine gaps.
The SADC Region has been identified as the preferred site for AfriPharma's Phase 2 sterile injectable manufacturing facility — strategically positioned for SADC-wide distribution.
AfriPharma's distribution operations are structured to generate the commercial track record and cash flows needed to support DFI financing — IFC, AfDB, and DFC — for the manufacturing phase.
Manufacturing strategy is aligned from inception to WHO Prequalification — enabling access to institutional procurement through UNICEF Supply Division, UNFPA, and national tender programs.
We welcome conversations across the healthcare ecosystem — suppliers, investors, healthcare providers, government agencies, and families seeking Care360 support.
Looking for a compliant, reliable distribution partner in Zimbabwe or the SADC region? We'd like to hear from you.
Contact Distribution Team →AfriPharma is building a DFI-ready platform targeting IFC, AfDB, and DFC financing for its manufacturing phase. Investor materials available on request.
Request Investor Materials →Supporting a loved one in Zimbabwe or across Southern Africa? Care360 provides trusted, coordinated healthcare support across the distance.
Learn About Care360 →